Semaglutide’s Surprising Lung Benefits | Salt Lake City News

New research reveals semaglutide—behind Ozempic and Wegovy—may slash asthma attacks by 40% and cut COPD flare-ups by 20%, according to a European study analyzing UK health records. While anti-inflammatory effects may explain the lung benefits, experts warn more trials are needed before self-medication. Beyond respiratory health, emerging data links these drugs to lower psychiatric hospitalizations, reduced bone fractures, and fewer cardiovascular events—but caution remains over rare eye stroke risks, especially with Wegovy. Always consult your doctor before starting any treatment. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/d07f9147113eb529